Publications by authors named "Sarah A Aglan"

Breast cancer (BC) is a heterogenous disease with multiple pathways implicated in its development, progression, and drug resistance. Autophagy, a cellular process responsible for self-digestion of damaged organelles, had been recognized as eminent player in cancer progression and chemotherapeutic resistance. The haploinsufficiency of Beclin 1 (BECN1), autophagy protein, is believed to contribute to cancer pathogenesis and progression.

View Article and Find Full Text PDF

Egypt is the third most densely inhabited African country. Due to the economic burden and healthcare costs of overpopulation, genomic and genetic testing is a huge challenge. However, in the era of precision medicine, Egypt is taking a shift in approach from "one-size-fits all" to more personalized healthcare via advancing the practice of medical genetics and genomics across the country.

View Article and Find Full Text PDF

Background: Nestin is a neural stem cell protein that plays an important role in cancer stem cells (CSC) development and proliferation. It has been identified as a marker for newly formed endothelial cells and was shown to be preferentially expressed in basal and myoepithelial cells of the mammary gland. is long intergenic non-coding (linRNA) associated with tumorigenesis through promotion of epithelial-mesenchymal transition (EMT) and stemness as well.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Sarah A Aglan"

  • - Sarah A Aglan's research primarily focuses on the implications of autophagy and genetic factors in breast cancer development and progression, with significant findings on the correlation between BECN1 mRNA expression and tumor grade in breast cancer tissues.
  • - Aglan highlights the challenges and advancements in genomic medicine within Egypt, emphasizing a shift towards personalized healthcare in response to the economic burden of overpopulation and the need for tailored genetic testing.
  • - Additionally, her work includes the evaluation of serum biomarkers, such as Nestin and specific genetic polymorphisms, as potential screening tools for breast cancer in Egyptian women, suggesting their roles in cancer stem cell dynamics and tumorigenesis.*